Immunodiagnostic Systems Holdings plc provided revenue guidance for the year ended March 31, 2015. Total revenues are expected to be £45 million (2014: £52 million) in line with guidance given in September 2014. The decrease in revenue was driven by lower automated revenues, due to a low level of net placements, and continued significant decline in manual revenues, predominantly in 25OH vitamin D.